Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.630
0.00 (0.00%)
At close: Jan 21, 2025, 4:00 PM
1.590
-0.040 (-2.45%)
Pre-market: Jan 22, 2025, 4:33 AM EST
Heron Therapeutics Employees
Heron Therapeutics had 126 employees as of December 31, 2023. The number of employees decreased by 77 or -37.93% compared to the previous year.
Employees
126
Change (1Y)
-77
Growth (1Y)
-37.93%
Revenue / Employee
$1,093,151
Profits / Employee
-$221,960
Market Cap
247.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
HRTX News
- 4 weeks ago - Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina - PRNewsWire
- 6 weeks ago - Relief For Heron Therapeutics After The Court Win On Cinvanti - Seeking Alpha
- 7 weeks ago - U.S. District Court Upholds Validity of CINVANTI® Patents - PRNewsWire
- 2 months ago - Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PRNewsWire
- 2 months ago - Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - PRNewsWire
- 3 months ago - Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - PRNewsWire
- 3 months ago - Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - PRNewsWire